I
mportance
of
the
use
of
protocols
for
the
management
of
analgesia
and
sedation
in
pediatric
intensive
care
unit
R
ev
A
ssoc
M
ed
B
ras
2016; 62(6):602-609
609
50.
Burbano NH, Otero AV, Berry DE, Orr RA, Munoz RA. Discontinuation of
prolonged infusions of dexmedetomidine in critically ill children with heart
disease. Intensive Care Med. 2012; 38(2):300-7.
51.
Lam F, Ransom C, Grossett JM, Kelkhoff A, Seib PM, Schmitz ML, et al.
Safety and efficacy of dexmedetomidine in children with heart failure. Pediatr
Cardiol. 2013; 34(4):835-41.
52. Chrysostomou C, Toledo JS, Avolio T, Motoa M, Berry D, Morell VO, et al.
Dexmedetomidine use in a pediatric cardiac intensive care unit: Can we use
it in infants after cardiac surgery? Pediatr Crit Care Med. 2009; 10(6):654-60.
53.
Jiang L, Ding S, Yan H, Li Y, Zhang L, Chen X, et al. A retrospective
comparison of dexmedetomidine versus midazolam for pediatric patients
with congenital heart disease requiring postoperative sedation. Pediatr
cardiol. 2015; 36(5):993-9.
54.
Fernández-Carrión F, Gaboli M, González-Celador R, Gómez de Quero-
Masía PG, Fernández-de Miguel S, Murga-Herrera V, et al. [Withdrawal
syndrome in the pediatric intensive care unit. Incidence and risk factors].
Med Intensiva. 2013; 37(2):67-74.
55.
Birchley G. Opioid and benzodiazepine withdrawal syndromes in the
paediatric intensive care unit: a review of recent literature. Nurs Crit Care.
2009; 14(1):26-37.
56.
Franck LS, Harris SK, Soetenga DJ, Amling JK, Curley MA. The Withdrawal
Assessment Tool-1 (WAT-1): an assessment instrument for monitoring
opioid and benzodiazepine withdrawal symptons in pediatric patients.
Pediatr Crit Care Med. 2008; 9(6):573-80.
57. Cho HH, O’Connell JP, Cooney M, Inchiosa MA Jr. Minimizing tolerance
and withdrawal to prolonged pediatric sedation: case report and review of
the literature. J Intensive Care Med. 2007; 22(3):173-9.
58.
Lugo RA, MacLaren R, Cash J, Probble CG, Vernon DD. Enteral methadone
to expedite fentanyl discontinuation and prevent opioid abstinence syndrome
in the PICU. Pharmacotherapy. 2001; 21(12):1566-73.
59.
Fisher D, Grap MJ, Younger JB, Ameringer S, Elswick RK. Opioid withdrawal
signs and symptoms in children: frequency and determinants. Heart Lung.
2013; 42(6):407-13.
60. Tobias J. Tolerance, withdrawal, and physical dependency after long-term
sedation and analgesia of children in the pediatric intensive care unit. Crit
Care Med. 2000; 28(6):2122-2132.
61. Bowens CD, Thompson JA, Thompson MT, Breitzka RL, Thompson DG,
Sheeran PW. A trial of methadone tapering schedules in pediatric intensive
care unit patients exposed to prolonged sedative infusions. Pediatr Crit Care
Med. 2011; 12(5):504-11.
62.
Steineck KJ, Skoglund AK, Carlson MK, Gupta S. Evaluation of a pharmacist-
managed methadone taper. Pediatr Crit Care Med. 2014; 15(3):206-10.
63. Tobias J. Methadone: who tapers, when, where, and how? Pediatr Crit Care
Med. 2014; 15(3):268-70.
64. Anand KJS, Wilson DF, Berger J, Harrison R, Meert KL, Zimmerman J, et
al.; Eunice Kennedy Shriver National Institute of Child Health and Human
Development Collaborative Pediatric Critical Care Research Network.
Tolerance and withdrawal from prolonged opioid use in critically ill children.
Pediatrics. 2010; 125(5):e1208-25.
65.
Franck LS, Scoppettuolo LA, Wypji D, Curley MA. Validity and
generalizability of the Withdrawal Assessment Tool-1 (WAT-1) for
monitoring iatrogenic withdrawal syndrome in pediatric patients. Pain.
2012; 153(1):142-8.
66.
Ducharme C, Carnevale FA, Clermont M, Shea S. A prospective study of
adverse reactions to the weaning of opioids and benzodiazepines among
critically ill children. Intensive Crit Care Nurs. 2005; 21(3):179-86.
67. Oschman A, McCabe T, Kuhn RJ. Dexmedetomidine for opioid and
benzodiazepine withdrawal in pediatric patients. Am J Health-Syst Pharm.
2011; 68(13):1233-8.
68.
Silver G, Traube C, Kearney J, Kelly D, Yoon MJ, Nash Moyal W, et al.
Detecting pediatric delirium: development of a rapid observational assessment
tool. Intensive Care Med. 2012; 38(6):1025-31.
69.
Jackson P, Khan A. Delirium in critically ill patients. Crit Care Clin. 2015;
31(3):589-603.
70.
Daoud A, Duff JP, Joffe AR. Diagnostic accuracy of delirium diagnosis
in pediatric intensive care: a systematic review. Critical Care. 2014;
18(5):489.
71.
Silver G, Traube C, Gerber LM, Sun X, Kearney J, Patel A, et al. Pediatric
delirium and associated risk factors: a single-center prospective observational
study. Pediatr Crit Care Med. 2015; 16(4): 303-9.
72.
Brahmbhatt K, Whitgob E. Diagnosis and management of delirium in
critically ill infants: case report and review. Pediatrics. 2016; 137(3):e1-5.